首页> 外文期刊>Circulation research: a journal of the American Heart Association >Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
【24h】

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.

机译:Toll样受体4介导心肌梗塞后适应不良的左心室重塑并损害心功能。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Left ventricular (LV) remodeling leads to congestive heart failure and is a main determinant of morbidity and mortality following myocardial infarction. Therapeutic options to prevent LV remodeling are limited, which necessitates the exploration of alternative therapeutic targets. Toll-like receptors (TLRs) serve as pattern recognition receptors within the innate immune system. Activation of TLR4 results in an inflammatory response and is involved in extracellular matrix degradation, both key processes of LV remodeling following myocardial infarction. To establish the role of TLR4 in postinfarct LV remodeling, myocardial infarction was induced in wild-type BALB/c mice and TLR4-defective C3H-Tlr4(LPS-d) mice. Without affecting infarct size, TLR4 defectiveness reduced the extent of LV remodeling (end-diastolic volume: 103.7+/-6.8 microL versus 128.5+/-5.7 microL; P<0.01) and preserved systolic function (ejection fraction: 28.2+/-3.1% versus 16.6+/-1.3%; P<0.01), as assessed by MRI. In the noninfarcted area, interstitial fibrosis, and myocardial hypertrophy were reduced in C3H-Tlr4(LPS-d) mice. In the infarcted area, however, collagen density was increased, which was accompanied by fewer macrophages, reduced inflammation regulating cytokine expression levels (interleukin [IL]-1alpha, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, tumor necrosis factor-alpha, interferon-gamma, granulocyte/macrophage colony-stimulating factor), and reduced matrix metalloproteinase-2 (4684+/-515 versus 7573+/-611; P=0.002) and matrix metalloproteinase-9 activity (76.0+/-14.3 versus 168.0+/-36.2; P=0.027). These data provide direct evidence for a causal role of TLR4 in postinfarct maladaptive LV remodeling, probably via inflammatory cytokine production and matrix degradation. TLR4 may therefore constitute a novel target in the treatment of ischemic heart failure.
机译:左心室重塑导致充血性心力衰竭,是心肌梗死后发病率和死亡率的主要决定因素。预防左室重塑的治疗选择是有限的,因此有必要探索其他治疗靶点。 Toll样受体(TLR)充当先天免疫系统中的模式识别受体。 TLR4的激活导致炎症反应,并参与细胞外基质降解,这是心肌梗死后LV重塑的两个关键过程。为了建立TLR4在梗死后LV重塑中的作用,在野生型BALB / c小鼠和TLR4缺陷型C3H-Tlr4(LPS-d)小鼠中诱发了心肌梗塞。在不影响梗塞面积的情况下,TLR4缺陷减少了左室重塑的程度(舒张末期容积:103.7 +/- 6.8 microL对128.5 +/- 5.7 microL; P <0.01)并保留了收缩功能(射血分数:28.2 +/- 3.1)由MRI评估的百分比为16.6 +/- 1.3%; P <0.01)。在非梗塞区域,C3H-Tlr4(LPS-d)小鼠的间质纤维化和心肌肥大减少。然而,在梗塞区域,胶原蛋白密度增加,巨噬细胞减少,炎症调节细胞因子表达水平降低(白介素[IL] -1alpha,IL-2,IL-4,IL-5,IL-6,IL -10,IL-17,肿瘤坏死因子-α,干扰素-γ,粒细胞/巨噬细胞集落刺激因子)和基质金属蛋白酶2减少(4684 +/- 515对7573 +/- 611; P = 0.002)和基质金属蛋白酶9活性(76.0 +/- 14.3对168.0 +/- 36.2; P = 0.027)。这些数据直接证明了TLR4在梗死后适应不良的LV重塑中起因作用,可能是通过炎症性细胞因子的产生和基质降解引起的。因此,TLR4可能构成治疗缺血性心力衰竭的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号